牛卵母细胞及着床前胚胎发育的蛋白质组学研究进展

蛋白质组学作为一种能够全景式展示特定生物学过程的蛋白质表达谱的高通量研究手段,正被应用到越来越多的研究领域。牛的卵子发生以及着床前胚胎的生长发育都离不开蛋白质的一系列变化,通过蛋白质组学的研究手段可对牛卵母细胞成熟以及胚胎发育分子机制进行研究。前人通过构建成熟前后的卵母细胞或不同时期的着床前胚胎等的蛋白质组表达谱,来获得与卵母细胞成熟相关的标志蛋白,并对这些标志物进行验证和分析,将有利于理解牛卵母细胞成熟、体外受精及着床前胚胎发育的分子机制,为提高牛卵母细胞的成熟率以及胚胎的发育率及提高牛繁殖率等奠定基础。主要从双向聚丙烯酰胺凝胶电泳、色谱技术以及质谱技术等蛋白质组学研究手段为切入点,对蛋白质组学在牛卵母细胞和着床前胚胎发育过程中的研究进展进行综述,为进一步研究牛卵母细胞及附植前胚胎提供参考。     

关于小鼠裸卵体外成熟培养系统的研究

获取高质量的体外成熟卵母细胞是成功进行人类体外受精、动物胚胎生产和克隆的关键。尽管大多数哺乳动物卵母细胞能够在体外自发完成细胞核成熟,但卵母细胞成熟质量远不如体内成熟卵母细胞,其受精后胚胎发育能力较差。目前认为,这可能是由于体外成熟的卵母细胞的胞质成熟不充分造成的。研究表明,卵母细胞体外成熟培养系统与受精率和囊胚发育率有强相关性。     

组蛋白乙酰化与卵母细胞及胚胎的体外发育

组蛋白乙酰化及去乙酰化是表观遗传修饰一个重要部分,其对哺乳动物卵母细胞成熟和胚胎发育具有重要的调节作用。因此深入研究组蛋白乙酰化的发生机制,对于改善卵母细胞和早期胚胎的发育具有重要意义。对哺乳动物卵母细胞及胚胎发育过程中的组蛋白乙酰化动态修饰进行综述。     

小鼠母源因子对早期胚胎发育的影响

在脊椎动物中发育过程中,卵母细胞要经历MII期停滞、受精、早期胚胎发育的启动、胚胎基因组的转录激活、并指导完成个体的发育过程。同时,核移植过程中,分化的细胞核在去核的卵母细胞中能够重编程到胚胎早期的状态并能完成个体的发育过程。在这些发育过程中母源因子都发挥了极其的重要作用。在小鼠胚胎发育研究中发现,小鼠的基因组激活发生在2细胞期,这一时期标志着合子的发育由卵母细胞控制向胚胎控制的过渡,期间发生一系列复杂的生化过程。体外培养的小鼠的胚胎的发育阻断也易发生的2细胞时期。因此对卵母细胞及早期胚胎母源因子的研究,将有利于了解早期体外培养胚胎和克隆胚胎发育失败的原因,为提高体外培养和克隆胚胎发育的成功率提供理论的基础。     

不同直径山羊卵泡卵母细胞的发育特征及体外发育能力

目的研究山羊卵巢表面不同直径卵泡卵母细胞的发育特征及体外发育能力,优化山羊早期胚胎体外生产系统。方法收集繁殖期和非繁殖期山羊卵巢,采集表面直径小于1.5 mm、1.5-2.5 mm、2.5-3.5 mm和大于3.5 mm4种卵泡卵母细胞,以Hoechst33342染色检查核发育阶段;同时,利用体外培养方法观察不同直径卵泡卵母细胞的成熟、受精和早期胚胎发育能力。结果直径小于1.5 mm卵泡卵母细胞主要处于GVI期;1.5-2.5 mm卵泡卵母细胞以GVⅠ、GVⅡ和GVⅢ期为主;2.5-3.5 mm卵泡卵母细胞在GVⅡ到GVⅣ期间平均分布;大于3.5mm卵泡卵母细胞主要为GVⅢ到GVBD期。体外培养实验发现,直径小于1.5 mm卵泡卵母细胞仅有个别能完成成熟和卵裂;大于1.5 mm卵泡卵母细胞具有核成熟能力,能完成成熟和受精,但1.5-2.5 mm卵泡卵母细胞的受精卵通常阻滞于4-8细胞期;当卵泡直径大于2.5 mm时,卵母细胞才能较好地支持胚胎继续发育,其桑/囊胚的比例达到30%以上。卵泡卵母细胞的发育特征和体外发育能力与动物所处的繁殖季节无关。结论山羊卵巢上直径大于1.5 mm卵泡卵母细胞具有核成熟能力,大于2.5 mm卵泡卵母细胞能支持早期胚胎继续发育。     

胸腺肽-β4在小鼠卵母细胞和早期胚胎中的表达与分布规律

胸腺肽-β4(thymosin-β4,Tb4)是一种重要的 G-actin遮蔽因子(G-actin sequestering factor),在细胞微丝活动中有着调节G-actin活性的作用． 以往报道证实了Tb4在细胞中具有广泛的生理作用,但其在哺乳动物卵母细胞成熟和早期胚胎发育等方面的作用,迄今还没有系统的研究报道． 以昆明白小鼠卵巢、卵母细胞和早期胚胎作为实验材料,以免疫( 荧光) 组织化学和RT-PCR技术为主要研究方法,对Tb4的表达与分布进行了研究． 结果显示,Tb4在相关发育过程中,存在差异性的表达和定位变化．结果表明,在小鼠卵母细胞成熟和早期胚胎的发育过程,Tb4能够通过表达与分布的变化对细胞微丝活动和细胞增殖活动进行调控,对小鼠卵母细胞成熟、早期胚胎发育以及胚胎着床过程有重要的作用．     

胸腺肽-β4在小鼠卯母细胞和早期胚胎中的表达与分布规律

胸腺肽-β4(thymosin-β4,Tb4)是一种重要的G-actin遮蔽因子(G-actin sequestening factor),在细胞微丝活动中有着调节G-actin活性的作用.以往报道证实了Tb4在细胞中具有广泛的生理作用,但其在哺乳动物卵母细胞成熟和早期胚胎发育等方面的作用,迄今还没有系统的研究报道.以昆明白小鼠卵巢、卵母细胞和早期胚胎作为实验材料,以免疫(荧光)组织化学和RT-PCR技术为主要研究方法,对Tb4的表达与分布进行了研究.结果显示,Tb4在相关发育过程中,存在差异性的表达和定位变化.结果表明,在小鼠卵母细胞成熟和早期胚胎的发育过程,Tb4能够通过表达与分布的变化对细胞微丝活动和细胞增殖活动进行调控,对小鼠卵母细胞成熟、早期胚胎发育以及胚胎着床过程有重要的作用.     

哺乳动物卵母细胞成熟和受精中细胞骨架重组和作用

卵母细胞成熟和受精是动物生殖过程的核心环节。细胞骨架是遍布于卵母细胞胞质中的一种复杂的蛋白质纤维网络,研究表明,卵母细胞成熟和受精过程中伴随着广泛的胞质骨架重组。哺乳动物卵母细胞和早期胚胎中细胞骨架具有其独特的分布和功能,使卵母细胞和胚胎呈现出不同的变化特点。微丝、微管的分布变化与卵母细胞成熟和受精中遗传物质的重组密切相关。近年来,对哺乳动物不同物种间卵母细胞和胚胎中细胞骨架成分的研究取得了很大的进展,结合这些研究成果,对哺乳动物卵母细胞成熟和受精过程中细胞骨架的重组、分布和作用进行了介绍。同时,对多种信号转导途径参与卵母细胞成熟和受精中细胞骨架系统的调控也作了探讨。     

哺乳动物腔前卵泡体外培养研究进展

哺乳动物卵巢中含有数以万计的腔前卵泡（preantral follicles）,仅不足1％能够发育至预排卵卵泡。建立哺乳动物腔前卵泡有效分离及体外培养技术体系,能够大量利用腔前卵泡,增加体外成熟卵母细胞数量,对哺乳动物胚胎体外生产、克隆及转基因动物生产等胚胎工程技术的研究与应用,以及在体外条件下揭示哺乳动物卵泡发育机理,都具有重要的理论意义和实用价值。鉴于卵巢质地与卵泡划、发生周期的固有差异,不同物种腔前卵泡分离方法与培养方式亦有所不同。同时,培养基类型、卵泡问相互作用、促性腺激素与细胞因子等因素均会对卵泡的体外发育产生影响。系统阐述了腔前卵泡的分离方法、培养方式以及相关因素对卵泡发育的影响,期望为从事相关研究的学者提供参考。     

哺乳动物雌性生殖细胞及早期胚胎基因敲除或敲减的方法

哺乳动物雌性生殖细胞为胚胎的形成和发育提供了大量母源性遗传物质。受精一旦实现,所形成的早期胚胎通过细胞分裂与分化逐渐形成具有复杂结构的全新个体。针对雌性生殖细胞(主要是卵母细胞)的相关研究既能解析其独有的生理学特性,又能为其他类型细胞的相关研究提供借鉴作用。然而,哺乳动物卵母细胞数量稀少,且不能在体外进行扩增培养,导致针对卵母细胞的相关研究难度极大。哺乳动物早期胚胎的研究也同样面临材料短缺的问题。在以卵母细胞和早期胚胎为材料的研究中,针对特定基因功能的失活或干扰是最常用的方法之一。本文将结合他人和本研究组在哺乳动物雌性生殖细胞及早期胚胎中进行的基因功能敲除或敲减实验,对条件性基因敲除、RNA干扰、Morpholino、Trim-Away和抗体介导的蛋白功能干扰这几类技术的主要方法原理、案例、优缺点和使用注意事项进行总结分析,并提出未来相关技术可能的改进方向,以期为从事卵母细胞及早期胚胎发育研究的科技工作者提供参考。     

Oocyte maturation: emerging concepts and technologies to improve developmental potential in vitro

Oocyte in vitro maturation (IVM) is an important reproductive technology that generates mature oocytes that are capable of supporting preimplantation embryo development and full development to term. There is great clinical and commercial incentive to improve the efficiency of the technology, however, progress has been slow over the past decade. A critical challenge is to understand what constitutes oocyte developmental competence and the mechanisms governing it. We have taken the approach of studying in detail oocyte-somatic cell interactions; including, oocyte-cumulus cell (CC) gap-junctional communication, and bidirectional paracrine signalling between the two cell types. It is becoming clear that, compared to oocytes matured in vivo, IVM oocytes undergo maturation prematurely as they are still in the process of acquiring developmental competence in vivo, and the molecular cascade reinitiating meiosis differs entirely to that in vivo. Attempts to enhance oocyte developmental competence by attenuating the spontaneous meiotic resumption of oocytes in vitro have been met with mixed success. Kinase inhibitors that prevent maturation-promoting factor activity have, in general, been ineffectual on promoting oocyte developmental potential post-IVM. In contrast, agents that modulate oocyte cAMP during IVM show greater potential, possibly as these compounds extend oocyte-CC gap-junctional communication. An important concept that is now emerging is that the oocyte secretes potent growth factors that regulate fundamental aspects of CC function and thereby determine the distinctive phenotype of the cumulus-oocyte complex. The capacity of an oocyte to regulate its own microenvironment by oocyte-secreted factors (OSFs) may constitute an important component of oocyte developmental competence. In support of this notion, we have recently demonstrated that supplementing IVM media with exogenous OSFs improves oocyte developmental potential, as evidenced by enhanced pre- and post-implantation embryo development.     

Control of oocyte maturation in cows--biological factors

Since bovine in vitro fertilization became possible in the early 80s, a lot of effort has been done to clarify the mechanisms of what seems more and more one of the crucial steps in this procedure, being oocyte maturation. Undoubtedly, many biological factors act together to prepare the immature oocyte for a successful development to a competent embryo after fertilization. Defects in oocyte maturation can possibly be caused by an inadequate nuclear or cytoplasmic maturation or even by a failure of both. There is a general agreement upon the fact that the origin of the oocyte can play an important role. Oocytes derived from very small follicles show a lower rate of maturation and lower blastocyst development with currently used maturation protocols. Parthenogenetic activation of small size follicle derived oocytes suggests that their poor development was not caused by fertilization problems but more likely by intrinsic oocyte factors. Similar developmental rates achieved through nuclear transfer and parthenogenetic activation suggests that the nucleus of the incompetent oocyte may not be the sole reason for a poor development. Another important factor appears to be the donor animal age. The younger the donor animal, the more impaired is its oocyte's developmental competence in most of the embryo IVP systems. Treatment with exogeneous gonadotropins can be beneficial in young donors on the oocyte cleavage rates but does not always increase the final blastocyst outcome. This review briefly documents some of the biological factors and their possible effects on the developmental capacities of the bovine oocyte in vitro.     

Responses of oocytes and embryos to the culture environment

Embryo development is strongly influenced by events occurring during oocyte maturation. Although many immature oocytes are capable of completing meiosis in vitro, only a small percentage of the original pool of immature oocytes is competent to continue development to the blastocyst stage and subsequently result in a pregnancy. This indicates that maturation of oocytes in vitro may not be occurring in an entirely normal manner. Cytoplasmic changes occurring during maturation, collectively termed cytoplasmic maturation, are essential for embryonic development. The cytoplasm of the oocyte may play a crucial role in assembling the correct metabolic machinery for production of sufficient energy for cellular functions during maturation, cleavage and blastocyst formation. A better understanding of the structural, functional and metabolic characteristics of the oocyte during maturation, and the consequence of changes in these parameters on developmental competence is needed. Understanding the role of cytoplasmic changes during oocyte maturation will help increase the efficiency of in vitro embryo production. Better embryo production strategies will facilitate basic research into the control of early development, improve implementation in endangered species, provide a source of high quality oocytes for nuclear transfer and transgenic technologies and benefit the commercial embryo transfer industry.     

A comparative analysis of metabolism and viability in porcine oocytes during in vitro maturation

The importance of oocyte quality cannot be overstated, because it impacts all subsequent events during development of the embryo, the fetus and even the resulting offspring. Oocyte metabolism plays a critical role in supporting developmental competence via multiple mechanisms. It is beginning to be understood that metabolic pathways not only affect cytoplasmic maturation but may control nuclear maturation as well. A complete understanding of the precise roles that metabolism plays in determining oocyte quality is crucial for developing efficient in vitro maturation systems to support acquisition of oocyte competence. To date, this pursuit has not been entirely successful. Work in our laboratory on porcine oocyte metabolism has elucidated some of the intricate control mechanisms at work within the oocyte, not only for energy production, but also encompassing progression of nuclear maturation, mitochondrial activity and distribution, and oxidative and ionic stresses. We hypothesize that by utilizing oocyte metabolic data, we can develop more appropriate in vitro maturation systems that result in increased oocyte and embryo developmental competence.     

Role of hyaluronic acid in maturation and further early embryo development of bovine oocytes

Hyaluronic acid (HA), an important component of the extracellular matrix, plays a crucial role for cumulus cell expansion. Genes and proteins involved in HA synthesis and its receptor CD44 are expressed in cumulus oocyte complexes (COCs) in different animal species and increase during maturation. Hyaluronidase enzymes (Hyal) degrade HA into smaller biologically active HA fragments. To investigate the effects of the molecular size and concentration of HA on oocyte maturation and further embryo development, bovine oocytes were matured in vitro in the presence or absence of HA, Hyal-2 or 4-methylumbelliferone (4-MU); an HA synthesis inhibitor. The rates of oocyte nuclear maturation to metaphase II stage and development of embryos to blastocyst stage and blastocyst quality were recorded. Hyal-2 inhibited cumulus cell expansion without affecting oocyte maturation and further embryo development. Whereas, 4-MU at 1 mm reduced cumulus cell expansion, oocyte maturation rate and further embryo development; an effect which was partially abrogated by exogenous HA supplementation. These data suggest that HA production by cumulus cells during maturation is essential not only for cumulus cell expansion, but also for oocyte maturation and further embryo development. This effect is not affected by HA-degradation by Hyal-2.     

A review of in vitro gamete maturation and embryo culture and potential impact on future animal biotechnology

This review considers the relationship of in vitro gamete maturation and embryo culture to the future development of animal biotechnology. The areas reviewed are oocyte maturation in vitro and embryo culture and their importance for successful in vitro embryo production. The rapidly developing area of spermatogonial cell transplantation and culture is also reviewed. The scientific milestones leading to the development of each area, the problems and prospects for future development and the possible significance of major advances in each area are discussed.